HNB
QNRX

Huntington National Bank’s Quoin Pharmaceuticals QNRX Stock Holding History

Huntington National Bank’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Hold
1
– – ﹤0.01% 3887
2025
Q4 		$6 Hold
1
– – ﹤0.01% 3801
2025
Q3 		$6 Hold
1
– – ﹤0.01% 3830
2025
Q2 		$6 Buy
+1
New +$8 ﹤0.01% 3836
2025
Q1 		– Hold
0
– – – 3847
2024
Q4 		– Hold
0
– – – 3858
2024
Q3 		– Hold
0
– – – 3851
2024
Q2 		– Hold
0
– – – 3798
2024
Q1 		– Hold
0
– – – 3672
2023
Q4 		– Hold
0
– – – 3575
2023
Q3 		– Hold
0
– – – 3548
2023
Q2 		– Hold
0
– – – 3504
2023
Q1 		– Hold
0
– – – 3366
2022
Q4 		– Hold
0
– – – 3234
2022
Q3 		– Hold
0
– – – 2317
2022
Q2 		– Hold
0
– – – 2344
2022
Q1 		– Hold
0
– – – 2298
2021
Q4 		– Hold
0
– – – 2251
2021
Q3 		– Hold
0
– – – 1690

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Huntington National Bank's QNRX Position: Q1 2026 in Review

Huntington National Bank held its Quoin Pharmaceuticals (QNRX) position steady in Q1 2026 at 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #3887.

Huntington National Bank first reported a position in QNRX in Q2 2025 and has held it in 4 quarters since. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Huntington National Bank held 1 share of Quoin Pharmaceuticals worth $6 as of Q1 2026.
  • Huntington National Bank left its Quoin Pharmaceuticals share count unchanged in Q1 2026.
  • Quoin Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3887 holding.
  • Huntington National Bank first reported a position in Quoin Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.